In today’s competitive pharmaceutical landscape, formulation teams are under increasing pressure to advance their parenteral drug products. They must balance the selection of the best drug delivery technology with timelines, manufacturability, performance, patient safety, and regulatory success. Among the most powerful formulation strategies available are two long-established drug delivery platforms: long-acting injectables based on bioabsorbable lactide/glycolide polymers - such as RESOMER
® and LACTEL
® - and liposomes and nanoparticles based on lipid excipients. Both drug delivery technologies, with already proven success on the market, offer unique advantages, challenges, pathways to differentiation and clinical success.
In this online session, experts from Evonik will compare these parenteral drug delivery platforms. You’ll gain a clearer understanding of where each platform excels, how drug property requirements differ, what development considerations matter most, and how Evonik’s end-to-end expertise can help you select the optimal path to developing a successful drug product.
While the webinar is not intended to provide generic-specific development strategies, it will help you recognize those formulation principles that can be leveraged to develop your drug product whether it’s a generic or new drug product.
